Web Analytics

Investor Profile

Debiopharm

Debiopharm Switzerland - Lausanne
INVESTOR

1 Disclosed Funding Rounds $16,428,000
2 Participating Investments




Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select lar

Invested In

Company Date Round Raised
  Iktos March, 10 ,2023 Series A $16,428,000
  Genialis March, 30 ,2023 Series A $13,000,000